-
公开(公告)号:US20050118679A1
公开(公告)日:2005-06-02
申请号:US10979092
申请日:2004-11-02
申请人: Jian Ni , Steve Ruben , Laurie Brewer , Reiner Gentz , Craig Rosen
发明人: Jian Ni , Steve Ruben , Laurie Brewer , Reiner Gentz , Craig Rosen
IPC分类号: A61K38/00 , C07K14/47 , C07K14/705 , C07K14/735 , C12N1/21 , C12N9/00 , C12N9/64 , C12N15/57 , C07H21/04 , A61K39/395 , C07K16/40
CPC分类号: C12N9/6489 , A61K38/00 , C07K14/47 , C07K14/705 , C07K14/70535 , C12N9/00 , C12N9/6475 , C12N9/6491 , C12N2799/026
摘要: The present invention relates to novel metalloproteinase-like proteins. In particular, isolated nucleic acid molecules are provided encoding the human TACE-like and matrilysin-like proteins. TACE-like and matrilysin-like polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TACE-like and matrilysin-like activity. Also provided are diagnostic methods for detecting cancer and therapeutic methods for cancer and other disorders characterized by an over or under production of these metalloproteinases.
摘要翻译: 本发明涉及新型金属蛋白酶样蛋白质。 特别地,提供了分离的核酸分子,其编码人类TACE样和基质溶素样蛋白。 TACE样和基质溶素样多肽也可以作为载体,宿主细胞和用于制备它们的重组方法提供。 本发明进一步涉及用于鉴定TACE样和基质溶素样活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测癌症的诊断方法和癌症的治疗方法以及特征在于这些金属蛋白酶过度或过量生产的其它病症。
-
公开(公告)号:US06261801B1
公开(公告)日:2001-07-17
申请号:US09006353
申请日:1998-01-13
申请人: Ying-Fei Wei , Reiner Gentz , Jian Ni , Steven M. Ruben
发明人: Ying-Fei Wei , Reiner Gentz , Jian Ni , Steven M. Ruben
IPC分类号: C12P2102
CPC分类号: C07K14/70578 , A61K48/00
摘要: The present invention relates to a novel human gene encoding a polypeptide which is a member of the TNF receptor family, and has now been found to bind TRAIL. More specifically, an isolated nucleic acid molecule is provided encoding a human polypeptide named tumor necrosis factor receptor-5, sometimes referred to as “TNFR-5” or “TR5”, and now referred to hereinafter as “TRAIL receptor without intracellular domain” or “TRID.” TRID polypeptides are also provided, as are vectors, host cells, and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists or antagonists of TRAIL polypeptide activity. Also provided are diagnostic and therapeutic methods utilizing such compositions.
摘要翻译: 本发明涉及编码作为TNF受体家族成员的多肽的新型人基因,现已发现其结合TRAIL。 更具体地,提供编码称为肿瘤坏死因子受体-5(有时称为“TNFR-5”或“TR5”)的人多肽的分离的核酸分子,以下在下文中称为“没有细胞内结构域的TRAIL受体”或 “TRID”。 还提供了TRID多肽,载体,宿主细胞以及用于制备它们的重组方法也是如此。 本发明还涉及用于鉴定TRAIL多肽活性的激动剂或拮抗剂的筛选方法。 还提供了利用这种组合物的诊断和治疗方法。
-
53.
公开(公告)号:US5998164A
公开(公告)日:1999-12-07
申请号:US467948
申请日:1995-06-06
申请人: Yi Li , Liang Cao , Jian Ni , Reiner Gentz , Carol J. Bult , Granger G. Sutton, III , Craig A. Rosen
发明人: Yi Li , Liang Cao , Jian Ni , Reiner Gentz , Carol J. Bult , Granger G. Sutton, III , Craig A. Rosen
IPC分类号: A61K38/00 , A61K48/00 , C07K14/705 , C07K14/715 , C12N15/12 , C12N15/62
CPC分类号: C07K14/7158 , C07K14/705 , A61K38/00 , A61K48/00
摘要: Human G-protein coupled receptor or polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides and methods of using the agonists and antagonists therapeutically to treat conditions related to the underexpression and overexpression of the G-protein coupled receptor polypeptides, respectively. Also disclosed are diagnostic methods for detecting a mutation in the G-protein coupled receptor nucleic acid sequences and an altered level of the soluble form of the receptors.
摘要翻译: 公开了人G-蛋白偶联受体或多肽和编码此类多肽的DNA(RNA)和通过重组技术产生此类多肽的方法。 还公开了利用这些多肽来鉴定此类多肽的拮抗剂和激动剂的方法,以及分别在治疗上使用激动剂和拮抗剂治疗与G蛋白偶联受体多肽的低表达和过表达相关的病症的方法。 还公开了用于检测G蛋白偶联受体核酸序列中的突变和受体的可溶形式的改变水平的诊断方法。
-
公开(公告)号:US5849286A
公开(公告)日:1998-12-15
申请号:US464604
申请日:1995-06-05
申请人: Jian Ni , Reiner Gentz , Mark D. Adams
发明人: Jian Ni , Reiner Gentz , Mark D. Adams
CPC分类号: C12N9/93 , C12Y603/02019 , A61K38/00
摘要: Human UCE 7, UCE 8 and UCE 9 polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods of utilizing such polypeptide for the treatment of the proliferation of malignant cells. Antagonists against such polypeptides and their uses as a therapeutic to treat Alzheimer's disease, atrophying skeletal muscle, African swine fever virus and apoptotic cell death are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in UCE 7, 8 and 9 nucleic acid sequences and the concentration of polypeptides encoded by such sequences.
摘要翻译: 公开了人类UCE 7,UCE 8和UCE 9多肽和编码这些多肽的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这种多肽来治疗恶性细胞增殖的方法。 还公开了抗这种多肽的拮抗剂及其作为治疗性阿尔茨海默氏病,萎缩性骨骼肌,非洲猪瘟病毒和凋亡性细胞死亡的治疗剂的用途。 还公开了用于检测与UCE 7,8和9核酸序列中的突变相关的疾病的诊断测定以及由这些序列编码的多肽的浓度。
-
公开(公告)号:US20050287606A1
公开(公告)日:2005-12-29
申请号:US11206746
申请日:2005-08-19
申请人: Jian Ni , Reiner Gentz , Craig Rosen
发明人: Jian Ni , Reiner Gentz , Craig Rosen
IPC分类号: A61K38/00 , C07H21/04 , C07K14/54 , C07K14/705 , C07K16/28 , G01N33/53 , G01N33/567
CPC分类号: C07K14/54 , A61K38/00 , G01N2333/54
摘要: The present invention concerns a novel T1R-like ligand I protein. In particular, isolated nucleic acid molecules are provided encoding the T1R-like ligand I protein. T1R-like ligand I polypeptides are also provided, as are recombinant vectors and host cells for expressing the same.
摘要翻译: 本发明涉及一种新型的T1R样配体I蛋白。 特别地,提供编码T1R样配体I蛋白的分离的核酸分子。 还提供了T1R样配体I多肽,重组载体和用于表达它们的宿主细胞也是如此。
-
公开(公告)号:US20050255100A1
公开(公告)日:2005-11-17
申请号:US11182946
申请日:2005-07-18
申请人: Ying-Fei Wei , Jian Ni , Reiner Gentz , Steven Ruben
发明人: Ying-Fei Wei , Jian Ni , Reiner Gentz , Steven Ruben
IPC分类号: A61K31/522 , A61K31/66 , A61K38/00 , A61K38/13 , A61K38/17 , A61K38/19 , A61K38/20 , A61K38/21 , A61K39/395 , A61K45/06 , A61K48/00 , C07K14/705 , C07K16/28
CPC分类号: A61K31/522 , A61K31/66 , A61K39/395 , A61K45/06 , A61K48/00 , A61K2039/505 , C07K14/70578 , C07K16/2878 , C07K2319/00 , C07K2319/30 , C12N2799/026 , A61K2300/00
摘要: The present invention relates to a novel human gene encoding a polypeptide which is a member of the TNF receptor family, and has now been found to bind TRAIL. More specifically, an isolated nucleic acid molecule is provided encoding a human polypeptide named tumor necrosis factor receptor-5, sometimes referred to as “TNFR-5” or “TR5,” and now referred to hereinafter as “TRAIL receptor without intracellular domain” or “TRID.” TRID polypeptides are also provided, as are vectors, host cells, and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists or antagonists of TRAIL polypeptide activity. Also provided are diagnostic and therapeutic methods utilizing such compositions.
摘要翻译: 本发明涉及编码作为TNF受体家族成员的多肽的新型人基因,现已发现其结合TRAIL。 更具体地,提供编码称为肿瘤坏死因子受体-5(有时称为“TNFR-5”或“TR5”)的人多肽的分离的核酸分子,以下在下文中称为“没有细胞内结构域的TRAIL受体”或 “TRID”。 还提供了TRID多肽,载体,宿主细胞以及用于制备它们的重组方法也是如此。 本发明还涉及用于鉴定TRAIL多肽活性的激动剂或拮抗剂的筛选方法。 还提供了利用这种组合物的诊断和治疗方法。
-
57.
公开(公告)号:US6090575A
公开(公告)日:2000-07-18
申请号:US467947
申请日:1995-06-06
申请人: Yi Li , Liang Cao , Jian Ni , Reiner Gentz , Carol J. Bult , Granger G. Sutton, III , Craig A. Rosen
发明人: Yi Li , Liang Cao , Jian Ni , Reiner Gentz , Carol J. Bult , Granger G. Sutton, III , Craig A. Rosen
IPC分类号: A61K48/00 , C07K14/705 , C12N15/12 , C12N5/10 , C12N15/62
CPC分类号: C07K14/705 , A61K48/00
摘要: Human G-protein coupled receptor polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides and methods of using the agonists and antagonists therapeutically to treat conditions related to the underexpression and overexpression of the G-protein coupled receptor polypeptides, respectively. Also disclosed are diagnostic methods for detecting a mutation in the G-protein coupled receptor nucleic acid sequences and an altered level of the soluble form of the receptors.
摘要翻译: 公开了人G-蛋白偶联受体多肽和编码此类多肽的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这些多肽来鉴定此类多肽的拮抗剂和激动剂的方法,以及分别在治疗上使用激动剂和拮抗剂治疗与G蛋白偶联受体多肽的低表达和过表达相关的病症的方法。 还公开了用于检测G蛋白偶联受体核酸序列中的突变和受体的可溶形式的改变水平的诊断方法。
-
公开(公告)号:US5968797A
公开(公告)日:1999-10-19
申请号:US903396
申请日:1997-07-22
申请人: Jian Ni , Reiner Gentz , Mark D. Adams
发明人: Jian Ni , Reiner Gentz , Mark D. Adams
摘要: Human UCE 7, UCE 8 and UCE 9 polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods of utilizing such polypeptide for the treatment of the proliferation of malignant cells. Antagonists against such polypeptides and their uses as a therapeutic to treat Alzheimer's disease, atrophying skeletal muscle, African swine fever virus and apoptotic cell death are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in UCE 7, 8 and 9 nucleic acid sequences and the concentration of polypeptides encoded by such sequences.
摘要翻译: 公开了人类UCE 7,UCE 8和UCE 9多肽和编码这些多肽的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这种多肽来治疗恶性细胞增殖的方法。 还公开了抗这种多肽的拮抗剂及其作为治疗性阿尔茨海默氏病,萎缩性骨骼肌,非洲猪瘟病毒和凋亡性细胞死亡的治疗剂的用途。 还公开了用于检测与UCE 7,8和9核酸序列中的突变相关的疾病的诊断测定以及由这些序列编码的多肽的浓度。
-
公开(公告)号:US5650313A
公开(公告)日:1997-07-22
申请号:US464342
申请日:1995-06-05
申请人: Jian Ni , Reiner Gentz , Mark D. Adams
发明人: Jian Ni , Reiner Gentz , Mark D. Adams
摘要: Human UCE 7, UCE 8 and UCE 9 polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods of utilizing such polypeptide for the treatment of the proliferation of malignant cells. Antagonists against such polypeptides and their uses as a therapeutic to treat Alzheimer's disease, atrophying skeletal muscle, African swine fever virus and apoptotic cell death are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in UCE 7, 8 and 9 nucleic acid sequences and the concentration of polypeptides encoded by such sequences.
摘要翻译: 公开了人类UCE 7,UCE 8和UCE 9多肽和编码这些多肽的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这种多肽来治疗恶性细胞增殖的方法。 还公开了抗这种多肽的拮抗剂及其作为治疗性阿尔茨海默氏病,萎缩性骨骼肌,非洲猪瘟病毒和凋亡性细胞死亡的治疗剂的用途。 还公开了用于检测与UCE 7,8和9核酸序列中的突变相关的疾病的诊断测定以及由这些序列编码的多肽的浓度。
-
公开(公告)号:US20080015149A1
公开(公告)日:2008-01-17
申请号:US11773491
申请日:2007-07-05
申请人: Jian Ni , Reiner Gentz , Craig Rosen , Fu-Tong Lui
发明人: Jian Ni , Reiner Gentz , Craig Rosen , Fu-Tong Lui
IPC分类号: A61K38/17 , A61P11/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/08 , C07H21/04 , C07K14/435 , C07K16/18 , C12N15/63 , C12N5/10 , C12P21/00 , G01N33/53
CPC分类号: C12N9/6475 , A61K38/00 , A61K2039/505 , C07K14/47 , C07K14/4726 , C07K14/705 , C07K14/70535 , C07K16/18 , C07K16/2851 , C12N9/6489 , C12N9/6491 , C12N2799/026
摘要: The present invention relates to novel galectin 11 proteins which are members of the galectin superfamily. In particular, isolated nucleic acid molecules are provided encoding the human galectin 11 proteins. Galectin 11 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of galectin 11 activity. Also provided are diagnostic and therapeutic methods.
摘要翻译: 本发明涉及作为半乳凝素超家族成员的新型半乳凝素11蛋白。 特别地,提供了分离的核酸分子,其编码人galectin11蛋白。 还提供了Galectin11多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明进一步涉及用于鉴定galectin11活性的激动剂和拮抗剂的筛选方法。 还提供诊断和治疗方法。
-
-
-
-
-
-
-
-
-